Fournié-Zaluski MC - Search Results

1

[New painkillers inhibiting the physiological breakdown of endogenous opioids].

Roques BP, Fournié-Zaluski MC, Wurm M. Roques BP, et al. Among authors: fournie zaluski mc. Med Sci (Paris). 2012 May;28(5):476-8. doi: 10.1051/medsci/2012285011. Epub 2012 May 30. Med Sci (Paris). 2012. PMID: 22643000 Free article. French. No abstract available.

2

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Roques BP, Fournié-Zaluski MC, Wurm M. Roques BP, et al. Nat Rev Drug Discov. 2012 Apr;11(4):292-310. doi: 10.1038/nrd3673. Nat Rev Drug Discov. 2012. PMID: 22460123 Review.

3

New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment.

Poras H, Bonnard E, Dangé E, Fournié-Zaluski MC, Roques BP. Poras H, et al. Among authors: fournie zaluski mc. J Med Chem. 2014 Jul 10;57(13):5748-63. doi: 10.1021/jm500602h. Epub 2014 Jun 24. J Med Chem. 2014. PMID: 24927250

4

Inhibition of osteosarcoma-induced thermal hyperalgesia in mice by the orally active dual enkephalinase inhibitor PL37. Potentiation by gabapentin.

Menéndez L, Hidalgo A, Meana A, Poras H, Fournié-Zaluski MC, Roques BP, Baamonde A. Menéndez L, et al. Eur J Pharmacol. 2008 Oct 31;596(1-3):50-5. doi: 10.1016/j.ejphar.2008.07.043. Epub 2008 Jul 30. Eur J Pharmacol. 2008. PMID: 18692494

5

Modulation of disulfide dual ENKephalinase inhibitors (DENKIs) activity by a transient N-protection for pain alleviation by oral route.

Poras H, Bonnard E, Fournié-Zaluski MC, Roques BP. Poras H, et al. Among authors: fournie zaluski mc. Eur J Med Chem. 2015 Sep 18;102:58-67. doi: 10.1016/j.ejmech.2015.07.027. Epub 2015 Jul 17. Eur J Med Chem. 2015. PMID: 26241877

6

Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.

Le Guen S, Catheline G, Fournié-Zaluski MC, Roques BP, Besson JM, Buritova J. Le Guen S, et al. Brain Res. 2003 Mar 28;967(1-2):106-12. doi: 10.1016/s0006-8993(02)04231-2. Brain Res. 2003. PMID: 12650971

7

Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain.

Bonnard E, Poras H, Fournié-Zaluski MC, Roques BP. Bonnard E, et al. Among authors: fournie zaluski mc. Eur J Pharmacol. 2016 Oct 5;788:176-182. doi: 10.1016/j.ejphar.2016.05.041. Epub 2016 Jun 4. Eur J Pharmacol. 2016. PMID: 27266667

8

Structure of aminopeptidase N from Escherichia coli complexed with the transition-state analogue aminophosphinic inhibitor PL250.

Fournié-Zaluski MC, Poras H, Roques BP, Nakajima Y, Ito K, Yoshimoto T. Fournié-Zaluski MC, et al. Acta Crystallogr D Biol Crystallogr. 2009 Aug;65(Pt 8):814-22. doi: 10.1107/S090744490901779X. Epub 2009 Jul 17. Acta Crystallogr D Biol Crystallogr. 2009. PMID: 19622865 Free PMC article.

9

Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.

Boudinot E, Morin-Surun M, Foutz AS, Fournié-Zaluski M, Roques BP, Denavit-Saubié M. Boudinot E, et al. Pain. 2001 Feb 1;90(1-2):7-13. doi: 10.1016/s0304-3959(00)00382-1. Pain. 2001. PMID: 11166965

10

Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.

Buritova J, Le Guen S, Fournié-Zaluski MC, Roques BP, Besson JM. Buritova J, et al. Eur J Pain. 2003;7(3):241-9. doi: 10.1016/S1090-3801(02)00122-2. Eur J Pain. 2003. PMID: 12725847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters